Clearstead Advisors’s BlackRock Health Sciences Trust II BMEZ Stock Holding History

Clearstead Advisors’s Portfolio BMEZ Stock Details BMEZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$102K	Buy	6,666 +81	+1%	+$1.17K	﹤0.01%	1286
2026 Q1	$94.6K	Buy	6,585 +78	+1%	+$1.16K	﹤0.01%	1145
2025 Q4	$97.9K	Buy	6,507 +73	+1%	+$1.1K	﹤0.01%	1137
2025 Q3	$92.8K	Buy	6,434 +115	+2%	+$1.63K	﹤0.01%	1076
2025 Q2	$90.1K	Sell	6,319 -4,895	-44%	-$70K	﹤0.01%	1096
2025 Q1	$167K	Buy	11,214 +6,205	+124%	+$97.1K	﹤0.01%	873
2024 Q4	$72.1K	Sell	5,009 -10,400	-67%	-$161K	﹤0.01%	1089
2024 Q3	$244K	Buy	15,409 +175	+1%	+$2.76K	﹤0.01%	782
2024 Q2	$234K	Buy	+15,234	New	+$231K	﹤0.01%	769

Other funds holding BMEZ

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

SCM

Saba Capital Management New York $3.9B AUM 12.9% 1-Year Est. Return

Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

RCM

Rivernorth Capital Management West Palm Beach, Florida $2.1B AUM 2.15% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

PCM

Penserra Capital Management Orinda, California $13B AUM 71.84% 1-Year Est. Return

Clearstead Advisors's BMEZ Position: Q2 2026 in Review

Clearstead Advisors increased its BlackRock Health Sciences Trust II (BMEZ) stake by 1.2% in Q2 2026, buying an estimated $1.17K and bringing the position to 6,666 shares worth $102K. The position accounts for ﹤0.01% of the portfolio, ranked #1286.

Clearstead Advisors first reported a position in BMEZ in Q2 2024 and has held it in 9 quarters since. The position peaked at $244K in Q3 2024. 88 funds tracked by Wall St. Rank hold BMEZ as of Q2 2026.

Clearstead Advisors held 6,666 shares of BlackRock Health Sciences Trust II worth $102K as of Q2 2026.
Clearstead Advisors bought 81 BlackRock Health Sciences Trust II shares in Q2 2026, an estimated $1.17K.
BlackRock Health Sciences Trust II made up ﹤0.01% of Clearstead Advisors's portfolio in Q2 2026, its #1286 holding.
Clearstead Advisors first reported a position in BlackRock Health Sciences Trust II in Q2 2024 and has held it in 9 quarters since.
Clearstead Advisors's BlackRock Health Sciences Trust II position peaked at $244K in Q3 2024.
88 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust II as of Q2 2026.

Based on Clearstead Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.